-- New Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory -- MARLBOROUGH, Mass., June 18, 2018 /CNW/ -- Hologic, Inc. (Nasdaq: HOLX) announced ...
Hologic, Inc. HOLX recently announced the receipt of Health Canada approval for the new Panther Fusion system and Panther Fusion assays for respiratory virus infections. The Panther Fusion respiratory ...
Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...
Hologic, Inc. HOLX announced the expansion of the Panther Scalable Solutions (PSS) portfolio with product launches. The products are now commercially available in the United States and Europe. While ...
The addition of Hologic's Aptima HPV assay to the fully automated Panther system expands the ability of laboratories to run multiple tests from a single specimen. Hologic's Aptima HPV mRNA based assay ...
MARLBOROUGH, Mass., June 18, 2018 /CNW/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has obtained approval from Health Canada for its new Panther Fusion® system and Panther Fusion assays ...
Hologic, Inc. HOLX announced the expansion of the Panther Scalable Solutions (PSS) portfolio with product launches. The products are now commercially available in the United States and Europe. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results